XML 42 R27.htm IDEA: XBRL DOCUMENT
v3.23.2

Statements of Operations-Additional Information (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2023
Statements of Operations-Additional Information |
Schedule of revenues disaggregated by major product category and geographic region | Net Sales by Product Type ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2023 | ​ | 2022 | ​ | 2021
Animal Health | ​ | ​ |  |  | ​ |  | ​ | ​ | ​
MFAs and other | ​ | $ | 387,349 | ​ | $ | 361,538 | ​ | $ | 330,017
Nutritional specialties | ​ |  | 172,504 | ​ |  | 157,196 | ​ | ​ | 142,760
Vaccines | ​ |  | 99,998 | ​ |  | 88,321 | ​ | ​ | 72,939
Total Animal Health | ​ | $ | 659,851 | ​ | $ | 607,055 | ​ | $ | 545,716
Mineral Nutrition | ​ |  | 242,656 | ​ |  | 259,512 | ​ | ​ | 220,560
Performance Products | ​ |  | 75,382 | ​ |  | 75,694 | ​ | ​ | 67,074
Total | ​ | $ | 977,889 | ​ | $ | 942,261 | ​ | $ | 833,350
​ Net Sales by Region ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2023 |  | 2022 |  | 2021
United States | ​ | $ | 578,773 | ​ | $ | 561,803 | ​ | $ | 494,889
Latin America and Canada | ​ |  | 219,846 | ​ |  | 191,047 | ​ | ​ | 166,325
Europe, Middle East and Africa | ​ |  | 117,815 | ​ |  | 122,480 | ​ | ​ | 114,131
Asia Pacific | ​ |  | 61,455 | ​ |  | 66,931 | ​ | ​ | 58,005
Total | ​ | $ | 977,889 | ​ | $ | 942,261 | ​ | $ | 833,350
Schedule of interest expense, net | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 | ​ | 2023 |  | 2022 |  | 2021
Interest expense, net | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
2021 Term A loan | ​ | $ | 6,243 | ​ | $ | 8,962 | ​ | $ | 7,951
Revolving credit facility | ​ |  | 10,905 | ​ |  | 2,956 | ​ |  | 3,649
2023 Incremental Term Loan | ​ | ​ | 154 | ​ | ​ | — | ​ | ​ | —
2022 Term loan | ​ | ​ | 589 | ​ | ​ | — | ​ | ​ | —
Amortization of debt issuance costs | ​ |  | 727 | ​ |  | 590 | ​ |  | 833
Refinancing expense | ​ |  | — | ​ |  | — | ​ |  | 1,020
Other | ​ |  | 58 | ​ |  | 183 | ​ |  | 265
Interest expense | ​ |  | 18,676 | ​ |  | 12,691 | ​ |  | 13,718
Interest income | ​ |  | (3,355) | ​ |  | (816) | ​ |  | (838)
​ | ​ | $ | 15,321 | ​ | $ | 11,875 | ​ | $ | 12,880
Schedule of depreciation and amortization | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2023 |  | 2022 |  | 2021
Depreciation and amortization | ​ |  | ​ | ​ |  | ​ | ​ |  |
Depreciation of property, plant and equipment | ​ | $ | 24,316 | ​ | $ | 23,781 | ​ | $ | 23,165
Amortization of intangible assets | ​ |  | 9,696 | ​ |  | 8,924 | ​ |  | 8,715
Amortization of other assets | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5
​ | ​ | $ | 34,012 | ​ | $ | 32,705 | ​ | $ | 31,885
Schedule of amortization of intangible assets | ​
​ | ​ | ​ | ​
For the Year Ending June 30 |  | ​ |
2024 | ​ | $ | 9,375
2025 | ​ |  | 7,769
2026 | ​ |  | 6,805
2027 | ​ |  | 6,556
2028 | ​ |  | 6,531
Thereafter | ​ |  | 17,951
Total | ​ | $ | 54,987
Schedule of research and development expense | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
For the Year Ended June 30 |  | 2023 |  | 2022 |  | 2021
Research and development expense | ​ | $ | 24,395 | ​ | $ | 20,832 | ​ | $ | 17,759

X
- Definition Tabular disclosure of depreciation and amortization. + References No definition available. + Details
Name: | pahc_ScheduleOfDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of interest expense, net. + References No definition available. + Details
Name: | pahc_ScheduleOfInterestExpenseNetTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of research and development expense. + References No definition available. + Details
Name: | pahc_ScheduleOfResearchAndDevelopmentExpenseTableTextBlock
Namespace Prefix: | pahc_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IncomeStatementRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration